Suivi thérapeutique pharmacologique de la cyamémazine : comment interpréter une concentration ? Une revue de la littérature

Bourin, 2004, Preclinical and clinical pharmacology of cyamemazine : anxiolytic effects and prevention of alcohol and benzodiazepine withdrawal syndrome, CNS Drug Rev, 10, 219, 10.1111/j.1527-3458.2004.tb00023.x Bret, 2009, Prescribing patterns of antipsychotics in 13 French psychiatric hospitals, Encephale, 35, 129, 10.1016/j.encep.2008.03.007 2021 Peyrière, 2017, Prévalence de l’usage des antipsychotiques dans une cohorte de patients suivis dans un centre de soins, de prévention et d’accompagnement en addictologie (CSAPA), Therapies, 72, 166, 10.1016/j.therap.2016.11.045 Hiemke, 2011, AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011, Pharmacopsychiatry, 44, 195, 10.1055/s-0031-1286287 Hiemke, 2018, Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017, Pharmacopsychiatry, 51, 9 Benyamina, 2008, Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes, Eur J Pharmacol, 578, 142, 10.1016/j.ejphar.2007.09.025 Hameg, 2003, Affinity of cyamemazine, an anxiolytic antipsychotic drug, for human recombinant dopamine vs. serotonin receptor subtypes, Biochem Pharmacol, 65, 435, 10.1016/S0006-2952(02)01515-0 Benyamina, 2012, Potential role of cortical 5-HT(2A) receptors in the anxiolytic action of cyamemazine in benzodiazepine withdrawal, Psychiatry Res, 198, 307, 10.1016/j.psychres.2012.01.009 Le Marie, 2018, Existe-t-il un pouvoir addictogène de la cyamemazine ? Réflexions autour de cas cliniques, Fr J Psychiatry, 1, S132, 10.1016/S2590-2415(19)30354-X Khouri, 2017, le réseau français des centres régionaux de pharmacovigilance. Cyamemazine (Tercian®): Exploration of extrapyramidal syndrome cases contained in the French pharmacovigilance database, Therapie, 72, 345, 10.1016/j.therap.2016.07.004 ANSM. Tercian. 2012. Résumé des caractéristiques du produit. http://agence-prd.ansm.sante.fr/php/ecodex/rcp/R0213724.htm.[Consulté le 31 janvier 2022]. Briet, 2017, The anticholinergic impregnation scale: towards the elaboration of a scale adapted to prescriptions in French psychiatric settings, Therapie, 72, 427, 10.1016/j.therap.2016.12.010 Javelot, 2018, Les effets anticholinergiques en psychiatrie: on connaît, mais on s’adapte comment ?, Fr J Psychiatry, 1, S96, 10.1016/S2590-2415(19)30251-X Arbus, 2007, Characterization of human cytochrome P450 enzymes involved in the metabolism of cyamemazine, Eur J Pharm, 32, 357, 10.1016/j.ejps.2007.09.003 Hodé, 2011, Active cyamemazine metabolites in patients treated with cyamemazine (Tercian®): influence on cerebral dopamine D2 and serotonin 5-HT (2A) receptor occupancy as measured by positron emission tomography (PET), Psychopharmacology, 217, 315, 10.1007/s00213-011-2289-1 Tracqui, 1993, Toxicological data in a fatality involving cyamemazine, J Anal Toxicol, 17, 386, 10.1093/jat/17.6.386 Rop, 2001, Concentrations of cis(Z)-clopenthixol and trans(E)-clopenthixol in a lethal case involving zuclopenthixol, diazepam, and cyamemazine, J Anal Toxicol, 25, 348, 10.1093/jat/25.5.348 Baillif-Couniou, 2018, Repeated attempted homicide by administration of drugs documented by hair analysis, J Forensic Leg Med, 54, 82, 10.1016/j.jflm.2018.01.001 Alunni-Perret, 2003, Acute fatal poisoning with cyamemazine, Forensic Sci Int, 137, 13, 10.1016/S0379-0738(03)00260-3 Hodé, 2005, A positron emission tomography (PET) study of cerebral dopamine D2 and serotonine 5-HT2A receptor occupancy in patients treated with cyamemazine (Tercian), Psychopharmacology, 180, 377, 10.1007/s00213-005-2172-z Peyrière, 2009, Antipsychotics-induced ischaemic colitis and gastrointestinal necrosis: a review of the French pharmacovigilance database, Pharmacoepidemiol Drug Saf, 18, 948, 10.1002/pds.1801 Cadranel, 1999, Cyamamezine-induced acute hepatitis after unique massive intake: a case report, Eur J Gastroenterol Hepatol, 11, 451, 10.1097/00042737-199904000-00016 Proença, 2020, Identification and quantification of antipsychotics in blood samples by LC-MS-MS: case reports and data from three years of routine analysis, J Anal Toxicol, 44, 915, 10.1093/jat/bkaa100 Ghysel, 1994, Recherche et dosage de cyamémazine et de ses metabolites dans les liquides biologiques après une intoxication mortelle, Toxicorama, VI, 47 Darmanaden, 1992, Intoxication mortelle par cyamémazine, J Pharm Clin, 11, 306 Pounder, 1990, Post-mortem drug redistribution--a toxicological nightmare, Forensic Sci Int, 45, 253, 10.1016/0379-0738(90)90182-X Saar, 2012, The time-dependant post-mortem redistribution of antipsychotic drugs, Forensic Sci Int, 222, 223, 10.1016/j.forsciint.2012.05.028 Zhu, 2019, Antipsychotic drugs and sudden cardiac death: a literature review of the challenges in the prediction, management, and future steps, Psychiatry Res, 281, 112598, 10.1016/j.psychres.2019.112598 2021 Lancelin, 2010, Effect of cyamemazine on the steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: a preliminary retrospective study, Ther Drug Monit, 32, 757, 10.1097/FTD.0b013e3181fa57fe Airaudo, 1995, Disposable devices for the dispensing of oral drops. Study of photoprotectiveness and compatibility, J Biomater Sci Polym Ed, 7, 381, 10.1163/156856295X00391